B CELL ALL
Clinical trials for B CELL ALL explained in plain language.
Never miss a new study
Get alerted when new B CELL ALL trials appear
Sign up with your email to follow new studies for B CELL ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Last-Resort CAR-T therapy offered to leukemia patients with no other options
Disease control AVAILABLEThis program gives adults with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia (ALL) access to an experimental cell therapy called obecabtagene autoleucel (Obe-cel) when their manufactured dose doesn't meet commercial standards. Participants must have already had th…
Matched conditions: B CELL ALL
Sponsor: Autolus Limited • Aim: Disease control
Last updated May 06, 2026 16:14 UTC
-
Study investigates whether kids with B-ALL need a vaccine booster after immunotherapy
Knowledge-focused Recruiting nowThis study looks at children and young adults (up to age 21) who were treated for B-cell acute lymphoblastic leukemia (B-ALL) with a drug called blinatumomab. The goal is to see if their routine childhood vaccines still protect them after this treatment. If the vaccines are no lo…
Matched conditions: B CELL ALL
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated May 04, 2026 16:21 UTC